Archive for the ‘Uncategorized’ Category

« Older Entries
Newer Entries »

Article: What Does Genetics Tell Us About Chronic Pain?

Thursday, October 4th, 2018

From http://relief.news/genetics-tell-us-chronic-pain/

Posted in Uncategorized | No Comments »

portable ultrasound / wearable?

Thursday, October 4th, 2018

It’s a pocket-size ultrasound machine that connects to iphone. I wonder what happens with the data

https://newatlas.com/butterfly-iq-smartphone-ultrasound/51962/

Posted in Uncategorized | Tags: , , ,  | No Comments »

California just became the first state with an Internet of Things cybersecurity law – The Verge

Monday, October 1st, 2018

https://www.theverge.com/2018/9/28/17874768/california-iot-smart-device-cybersecurity-bill-sb-327-signed-law

Posted in Uncategorized | No Comments »

Opinion | Autumn Means More Than Wet Socks and Gourd Tea – The New York Times

Sunday, September 30th, 2018

https://www.nytimes.com/2018/09/29/opinion/konc-autumn-humor.html

Posted in Uncategorized | No Comments »

How to Build Strength – A year of living better Guides – The New York Times

Sunday, September 30th, 2018

https://www.nytimes.com/guides/year-of-living-better/how-to-build-muscle-strength

Posted in Uncategorized | No Comments »

Action potentials

Sunday, September 30th, 2018

https://faculty.washington.edu/chudler/ap.html

Posted in Uncategorized | Tags: , , ,  | No Comments »

Action potentials

Saturday, September 29th, 2018

Posted in Uncategorized | Tags: , , ,  | No Comments »

Weekender: Branford, Conn. – The New York Times

Saturday, September 29th, 2018

https://www.nytimes.com/2005/08/26/realestate/weekender-branford-conn.html

Posted in Uncategorized | Tags: ,  | No Comments »

Paul Singer, Doomsday Investor | The New Yorker

Saturday, September 29th, 2018

https://www.newyorker.com/magazine/2018/08/27/paul-singer-doomsday-investor

Posted in Uncategorized | No Comments »

FDA Approves Libtayo(R) (cemiplimab-rwlc) as First and Only Treatment for Advanced Cutaneous Squamous Cell Carcinoma

Saturday, September 29th, 2018

https://www.prnewswire.com/news-releases/fda-approves-libtayo-cemiplimab-rwlc-as-first-and-only-treatment-for-advanced-cutaneous-squamous-cell-carcinoma-300721188.html

Posted in Uncategorized | No Comments »

« Older Entries
Newer Entries »